Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanTreatment OutcomeMyeloablative AgonistsMultiple MyelomaStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsRecurrenceRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicRetrospective StudiesVidarabineImmunosuppressive AgentsHematopoiesisAmyloidosisLeukemiaSalvage TherapySurvival RateIfosfamideSurvival AnalysisVincristineBlood CellsGraft vs Leukemia EffectCarmustineTime FactorsCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountLiver TransplantationCytomegalovirus InfectionsMyelodysplastic SyndromesAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomeNeoplasmsFollow-Up StudiesOpportunistic InfectionsCyclosporineFeasibility StudiesKidney TransplantationLivedo ReticularisHistiocytosis, Non-Langerhans-CellHematologic DiseasesImmunosuppressionHLA AntigensBlood DonorsPrecursor Cell Lymphoblastic Leukemia-LymphomaDoxorubicinBone MarrowImmunophenotypingProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellPrednisonePilot ProjectsBone Marrow PurgingTransplantation ImmunologyCarboplatinBone Marrow DiseasesBlood Group IncompatibilityPrognosisAntigens, CDCell Transplantation